Fed. Circ. Won't Review Invalidity Ruling Over Yaz Patent
The Federal Circuit on Monday refused to reconsider its ruling that claims in a patent related to Bayer AG's Yaz contraceptive were invalid, shooting down a bid for a rehearing in...To view the full article, register now.
Already a subscriber? Click here to view full article